| Autor: |
Halford R; World Hepatitis Alliance, Geneva, Switzerland; The Hepatitis C Trust, London, UK., Hicks J; World Hepatitis Alliance, Geneva, Switzerland., Islam R; World Hepatitis Alliance, Geneva, Switzerland; The National Liver Foundation of Bangladesh, Dhaka, Bangladesh., James C; World Hepatitis Alliance, Geneva, Switzerland., Mendão L; World Hepatitis Alliance, Geneva, Switzerland; Grupo de Ativistas em Tratamentos (GAT) Portugal, Lisbon, Portugal., Shiha G; Gastroenterology and Hepatology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt., Smith A; World Hepatitis Alliance, Geneva, Switzerland. Electronic address: alexandra.smith@worldhepatitisalliance.org., Vélez-Möller P; World Hepatitis Alliance, Geneva, Switzerland; Asociación Guatemalteca del Hígado, Guatemala City, Guatemala; Universidad de San Carlos de Guatemala, Guatemala City, Guatemala. |
| Abstrakt: |
Competing Interests: The World Hepatitis Alliance has received grants from Abbott, AbbVie, Gilead, GlaxoSmithKline, the John C Martin Foundation, Kedrion, Roche, and Vir Biotechnology. |
